×
Masimo Common Stock Net 2010-2025 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo common stock net for the quarter ending March 31, 2025 was
$0M
, a
0% increase
year-over-year.
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Masimo common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Masimo common stock net for 2022 was
$0B
, a
0% decline
from 2021.
View More
Masimo Common Stock Net 2010-2025 | MASI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Masimo common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Masimo common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Masimo common stock net for 2022 was
$0B
, a
0% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$185.9B
Thermo Fisher Scientific (TMO)
$156.6B
Edwards Lifesciences (EW)
$44.9B
Alcon (ALC)
$43.1B
IDEXX Laboratories (IDXX)
$41.4B
DexCom (DXCM)
$32.9B
IQVIA Holdings (IQV)
$27.8B
Mettler-Toledo (MTD)
$24.8B
STERIS (STE)
$22.2B
SONOVA HOLDING (SONVY)
$17.4B
Waters (WAT)
$17.1B
Hologic (HOLX)
$14.3B
Sysmex ADR (SSMXY)
$10.4B
Penumbra (PEN)
$8.9B
Globus Medical (GMED)
$7.6B
Glaukos (GKOS)
$5.6B
Teleflex (TFX)
$4.9B
Integer Holdings (ITGR)
$3.9B
TransMedics (TMDX)
$3.7B
PROCEPT BioRobotics (PRCT)
$3.2B
LivaNova (LIVN)
$2.3B
Elekta AB (EKTAY)
$1.9B
Nihon Kohden (NHNKY)
$1.9B
Veracyte (VCYT)
$1.8B
Alphatec Holdings (ATEC)
$1.5B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$1B
Tandem Diabetes Care (TNDM)
$984M